Funded Biotechnology Startups in Ann Arbor
The disclosed funding sizes in this Ann Arbor biotechnology slice are headed by one outlier: ONL Therapeutics’ Series D on 2024-09-13 at $65M, which is the…
The disclosed funding sizes in this Ann Arbor biotechnology slice are headed by one outlier: ONL Therapeutics’ Series D on 2024-09-13 at $65M, which is the only disclosed round above $50M; the next-largest disclosed amounts shown are Strata Oncology at $90M (2021-07-28) and $20M from Akadeum Life Sciences (2025-06-03), with most others clustered between $2M and $9M (for example, Evoq Therapeutics at $2M on 2024-08-29 and Culturewell at $750K on 2026-05-29). Temporally, the most recent activity stacks in 2024–2025: 9 of the 13 rows fall between 2021-07-28 and 2025-10-13, with multiple entries in mid-2025 (Endra $5M on 2025-10-13 and Spike Neuro $3M on 2025-06-29) and mid-2024 (Genomenon $6M on 2024-05-16 and ONL Therapeutics $65M on 2024-09-13). Stage labeling is also skewed toward ambiguity: “Series Unknown” appears in 9 of 13 rows, while only 3 of the 13 rows have explicit series designations (Series B, C, or D) and two rows show undisclosed amounts (Esperion on 2026-05-01 and NOTA Labs on 2022-09-15). Geography stays consistent in Ann Arbor, Michigan across all entries, and the date window for these 13 rounds spans from 2021-07-28 (Strata Oncology) to 2026-05-29 (Culturewell).
Most recent rounds
13 shownRelated listings
Frequently asked
What are the size outliers in this Ann Arbor biotechnology set, and how do the rest of the disclosed rounds compare?
ONL Therapeutics’ disclosed $65M (Series D) on 2024-09-13 is the only disclosed round above $50M in the list; most other disclosed amounts sit in the $2M–$20M band (e.g., Culturewell at $750K on 2026-05-29 and Evoq Therapeutics at $2M on 2024-08-29). The largest disclosed amount overall is Strata Oncology’s $90M on 2021-07-28.
Do most rounds cluster in a particular time window, based on the round dates shown?
Activity is concentrated in the 2024–2025 portion of the window: 7 of 13 rounds occur between 2024-05-16 (Genomenon) and 2025-10-13 (Endra). There is also a tight recurrence in 2022-09-15 with two entries (Newhaptics at $2M and NOTA Labs with undisclosed amount).
Which stage labels dominate here, and how often are series details missing or amounts undisclosed?
“Series Unknown” appears in 9 of 13 rows, while explicit series labels appear in only 4 rows (Series B: HYGIEIA at $5M on 2023-05-02; Series C: Strata Oncology at $90M on 2021-07-28; Series D: ONL Therapeutics at $65M on 2024-09-13; and Series D is the only D shown). Undisclosed amounts show up twice (Esperion on 2026-05-01 and NOTA Labs on 2022-09-15).
Are there multiple entries with the same “round date” in this listing, suggesting synchronized funding events?
Yes: two separate entries share the same date 2022-09-15 (Newhaptics at $2M and NOTA Labs with undisclosed amount). Another notable concentration is in mid-2024, including Genomenon on 2024-05-16 ($6M) and ONL Therapeutics on 2024-09-13 ($65M).
How consistent is the geography across companies, and is any entry positioned differently by location?
Geography is fully consistent in the rows shown: all 13 companies are listed in Ann Arbor, Michigan, United States. There are no alternate city or state locations within this dataset to compare against.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.